South & Central America Health Economics and Outcome Research (HEOR) Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031

South & Central America Health Economics and Outcome Research (HEOR) Services Market Size and Forecast (2021-2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Economic Modelling or Evaluation, Real World Data Analysis and Information System, Market Access Solutions and Reimbursement, Clinical Outcome, Other Services), Service Provider (Contract Research Organizations and Consultancy), and End User (Biotechnology and Pharmaceutical Companies, Healthcare Payers, Government Organizations, and Healthcare Providers)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Code : TIPRE00041428
  • Category : Life Sciences
  • No. of Pages : 123
  • Available Report Formats : pdf-format excel-format
South & Central America Health Economics and Outcome Research (HEOR) Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Oct 2025   |   Report Code: TIPRE00041428
Buy Now

The South & Central America health economics and outcome research (HEOR) services market size is expected to reach US$ 214.03 million by 2031 from US$ 113.42 million in 2024. The market is estimated to record a CAGR of 9.5% from 2024 to 2031.

Executive Summary and South & Central America Health Economics and Outcome Research (HEOR) Services Market Analysis:

The Health Economics and Outcomes Research (HEOR) services market in South and Central America is steadily expanding, propelled by rising investments in the pharmaceutical and healthcare industries. Brazil and Argentina are major contributors to this expansion, while the broader region itself also has significant potential. Government initiatives that involve enhancing healthcare facilities and broadening access to sophisticated treatments are major driving forces behind this advancement. The rising expenditure on healthcare, expanding incidence of chronic ailments, and pressure for cost-effective healthcare services are driving demand for HEOR services. These services are crucial for determining the value of healthcare interventions and informing policy decisions. Additionally, strong regulatory frameworks and collaborations between the public and private sectors are creating more opportunities in Brazil and Argentina. As pharmaceutical companies seek insights into pricing, reimbursement, and market access, HEOR services are becoming increasingly important in shaping the healthcare landscape of these countries.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

South & Central America Health Economics and Outcome Research (HEOR) Services Market: Strategic Insights

south-and-central-america-health-economics-and-outcome-research-heor-services-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South & Central America Health Economics and Outcome Research (HEOR) Services Market Segmentation Analysis:

Key segments that contributed to the derivation of the South & Central America health economics and outcome research (HEOR) services market analysis are service, service provider, and end user.

  • Based on service, the South & Central America health economics and outcome research (HEOR) services market is segmented into economic modelling or evaluation, real world data analysis and information system, market access solutions and reimbursement, clinical outcome, and others. The economic modelling or evaluation segment held the largest share of the market in 2024.
  • By service provider, the South & Central America health economics and outcome research (HEOR) services market is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger share of the market in 2024.
  • By end user, the South & Central America health economics and outcome research (HEOR) services market is segmented into biotechnology and pharmaceutical companies, healthcare payers, government organizations, and healthcare providers. The biotechnology and pharmaceutical companies segment held the largest share of the market in 2024.

South & Central America Health Economics and Outcome Research (HEOR) Services Market Report Scope

Report Attribute Details
Market size in 2024 US$ 113.42 Million
Market Size by 2031 US$ 214.03 Million
CAGR (2024 - 2031) 9.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Service
  • Economic Modelling or Evaluation
  • Real World Data Analysis and Information System
  • Market Access Solutions and Reimbursement
  • Clinical Outcome
  • Others
By Service Provider
  • Contract Research Organizations
  • Consultancy
By End User
  • Biotechnology and Pharmaceutical Companies
  • Healthcare Payers
  • Government Organizations
  • Healthcare Providers
Regions and Countries Covered South & Central America
  • Brazil
  • Argentina
  • Rest of South & Central America
Market leaders and key company profiles
  • PharmaLex GmbH
  • ICON Plc
  • IQVIA Holdings Inc
  • Syneos Health Inc
  • Optum Inc
  • Certara Inc.
  • ExlService Holdings, Inc.
  • Avalon Health Economics LLC
  • Axtria, Inc.
  • McKesson Corp

South & Central America Health Economics and Outcome Research (HEOR) Services Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Health Economics and Outcome Research (HEOR) Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

south-and-central-america-health-economics-and-outcome-research-heor-services-market-cagr

South & Central America Health Economics and Outcome Research (HEOR) Services Market Outlook

The healthcare industry has significantly evolved since there is an integration of information technology, artificial intelligence, and digital technology. Healthcare digitalization has attracted several technology giants, such as Apple, Inc.; Amazon.com, Inc.; Alphabet Inc., and Microsoft Corporation, to enter the healthcare segments. For instance, Alphabet Inc.'s venture, Google is dedicatedly involved in life sciences, and its other ventures are investing in the healthcare industry. These companies have utilized their capability with technological development and have provided various wearable devices, digital apps, diagnostics technologies, and therapies that keep track of health and fitness.

Electronic medical records, telemedicine, and big data are a few of the healthcare digitalization. Microsoft Corporation has entered into artificial intelligence, and it is exploring the possibilities of transforming healthcare, genomics, telehealth, cloud computing, and cybersecurity for the healthcare industry.

Constant developments are being made by the core healthcare companies, contributing to the growth of the HEOR services market. For instance, in October 2023, Curavit Clinical Research, a virtual contract research organization (VCRO) specializing in decentralized clinical trials for digital therapeutics, launched a new Health Economics and Outcomes Research Practice. Curavit will integrate HEOR services into clinical trials to gather evidence on the health economic value of novel pharmaceutical products, particularly digital therapeutics, with the aim of accelerating market momentum. Furthermore, Curavit will evaluate the impact and effectiveness of DTx interventions on both individual and population healthcare levels.

South & Central America Health Economics and Outcome Research (HEOR) Services Market Country Insights

Based on country, the South & Central America health economics and outcome research (HEOR) services market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2024.

Health Economics & Outcomes Research (HEOR) Services focus on the economic evaluation of healthcare interventions, their outcomes, and cost-effectiveness. In Brazil, these services are crucial for both private and public companies as the country seeks to optimize resource allocation in healthcare amid financial constraints and a rapidly evolving healthcare landscape. As per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America and spends 9.1% of its GDP on healthcare.

The healthcare industry in Brazil is driven by pricing, with domestically produced goods offering a clear price advantage. Quality that satisfies legal requirements is also crucial. Healthcare decision-makers in Brazil, such as Sistema Único de Saúde - SUS, must justify expenditures on new technologies while adhering to the national budget constraints. HEOR services deliver essential data to evaluate the economic value of new treatments, enabling companies to present compelling cost-effectiveness analyses to decision-makers. By demonstrating that their products provide better outcomes at a reasonable cost, both local and international manufacturers can gain market access and secure reimbursement.

South & Central America Health Economics and Outcome Research (HEOR) Services Market Company Profiles

Some of the key players operating in the market include PharmaLex GmbH; ICON Plc; IQVIA Holdings Inc; Syneos Health Inc; Optum Inc; Certara Inc.; ExlService Holdings, Inc.; Avalon Health Economics LLC; Axtria, Inc.; and McKesson Corp, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Health Economics and Outcome Research (HEOR) Services Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Dec 2025